quinoxalines has been researched along with quindoxin in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (23.33) | 18.7374 |
1990's | 2 (3.33) | 18.2507 |
2000's | 18 (30.00) | 29.6817 |
2010's | 23 (38.33) | 24.3611 |
2020's | 3 (5.00) | 2.80 |
Authors | Studies |
---|---|
Frain-Bell, W; Gardiner, J | 1 |
Knüsel, F; Rosselet, A; Suter, W | 1 |
Hashimoto, T; Hayakawa, S; Hayatsu, H; Namba, T; Negishi, T | 1 |
Bakri, A; Beyersbergen van Henegouwen, GM; Bojarski, J; de Vries, H; Donker, AA | 1 |
Nishioka, H; Nunoshiba, T | 1 |
Bradbrook, C; Charlesworth, JD; Chu, YH; Cooper, DP; Margison, GP; O'Connor, PJ; Styles, J | 1 |
Kovacic, P; Ryan, MD; Scamehorn, RG | 1 |
Edwards, JR; Hennessey, TD | 1 |
Novácek, L; Seménková, L; Sevcík, B; Soska, J; Vavrínová, D | 1 |
Banjaw, K; Dibar, D; Flachowsky, G | 1 |
Scheutwinkel-Reich, M; vd Hude, W | 1 |
Arao, Y; Hayatsu, H; Negishi, K; Oka, N | 1 |
Cihák, R; Srb, V | 1 |
Beutin, L; Kowalski, B; Preller, E | 1 |
Novacek, L | 1 |
de Miguel, C; García, E; González, M; López de Ceráin, A; Martínez-Crespo, FJ; Monge, A; Narro, S; Palop, JA; Sainz, Y; Senador, V | 1 |
Bhansali, J; Chowdhury, G; Daniels, JS; Ganley, B; Gates, KS | 1 |
Assaad, C; Diab-Assef, M; Gali-Muhtasib, HU; Haddadin, MJ; Yared, P | 1 |
Carta, A; Paglietti, G; Rahbar Nikookar, ME; Sanna, P; Sechi, L; Zanetti, S | 1 |
Chignell, CF; Inbaraj, JJ; Motten, AG | 1 |
Al-Hmaira, J; Gali-Muhtasib, H; Geara, F; Haddadin, MJ; Mona, AD; Sidani, M; Zaatari, G | 1 |
Aldana, I; Jaso, A; Monge, A; Zarranz, B | 1 |
Diab-Assaf, M; Gali-Muhtasib, HU; Haddadin, MJ | 1 |
Bua, A; Cannas, S; Carta, A; Deriu, A; Molicotti, P; Paglietti, G; Sechi, LA; Zanetti, S | 1 |
Azqueta, A; Cascante, M; Creppy, EE; López de Cerain, A; Pachón, G | 1 |
Abram, U; Araujo, J; Azqueta, A; Cerecetto, H; Costa-Filho, AJ; Gambino, D; González, M; Lavaggi, ML; López de Cerain, A; Torre, MH; Vega, AM | 1 |
Carta, A; Corona, P; Loriga, M | 1 |
Adachi, Y; Cerecetto, H; Costa-Filho, AJ; Gambino, D; González, M; Lavaggi, ML; Noblía, P; Sakurai, H; Torre, MH; Vieites, M | 1 |
Aguirre, G; Arredondo, C; Basombrío, MA; Boiani, M; Cerecetto, H; Fernández, M; González, M; León, E; Pacheco, JP; Pintos, C; Raymondo, S | 1 |
Carmeli, M; Rozen, S | 1 |
Azqueta, A; Cia, F; de Cerain, AL; García-Jalón, JA; García-Rodríguez, A; Gil, AG; Monge, A; Zarranz, B | 1 |
Aldana, I; Bongard, E; Burguete, A; Charnaud, S; Lima, LM; Monge, A; Perez-Silanes, S; Solano, B; Vicente, E; Villar, R; Vivas, L | 1 |
Aldana, I; Ancizu, S; Burguete, A; Monge, A; Pérez-Silanes, S; Solano, B; Vicente, E; Villar, R | 1 |
Aldana, I; Cho, SH; Franzblau, SG; Goldman, RC; Lenaerts, AJ; Maddry, JA; Monge, A; Pérez-Silanes, S; Solano, B; Vicente, E; Villar, R | 1 |
Amin, KM; Ammar, YA; Ismail, MM; Noaman, E; Soliman, DH | 1 |
Benítez, D; Castro, EA; Cerecetto, H; Duchowicz, PR; González, M; Monge, A; Vicente, E | 1 |
El-Khatib, M; Gali-Muhtasib, H; Geara, F; Haddadin, MJ | 1 |
Aldana, I; Burguete, A; Cabanillas, B; Castillo, D; Deharo, E; Estevez, Y; Málaga, E; Monge, A; Pérez-Silanes, S; Quiliano, M; Verástegui, M; Zimic, M | 1 |
Goldman, RC | 1 |
Aldana, I; Goldman, RC; Mong, A; Pérez-Silanes, S; Vicente, E; Villar, R | 1 |
Fettinger, JC; Ghattass, KI; Haddadin, MJ; Kurth, MJ; Shoker, TA | 1 |
Fang, B; He, L; He, Q; Su, Y; Yang, J; Zeng, D; Zeng, Z | 1 |
Fernandes, R; Noronha, JP; Pinheiro, C; Prudêncio, C; Vieira, M | 1 |
Chen, Q; Deng, Y; Mu, P; Tang, X; Wang, L; Wang, Y; Wu, K; Xu, M; Zheng, M; Zheng, Y | 1 |
El-Sabban, M; El-Sitt, S; Gali-Muhtasib, H; Ghattass, K; Haddadin, MJ; Rayes, S; Zibara, K | 1 |
Anderson, RF; Denny, WA; Hay, MP; Marshall, AJ; Reynisson, J; Yadav, P | 1 |
Le, T; Shu, L; Zhang, L; Zhu, L | 1 |
Arbillaga, L; Azqueta, A; Cerecetto, H; González, M; Moreno-Viguri, E; Pérez-Silanes, S; Torres, E; Varela, J | 1 |
Chen, D; Cheng, G; Dai, M; Guo, P; Ihsan, A; Liu, Z; Luo, X; Wang, X; Yang, C; Yuan, Z | 1 |
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Aldana, I; Barea, C; Deharo, E; Galiano, S; Pabón, A; Quiliano, M; Ramirez-Calderon, G | 1 |
Andrade-Ochoa, S; Chacón-Vargas, KF; Juárez-Ramírez, DC; Lara-Ramírez, EE; Mondragón-Flores, R; Monge, A; Nogueda-Torres, B; Rivera, G; Sánchez-Torres, LE | 1 |
Aldana, I; Beltrán-Hortelano, I; Bonilla-Ramirez, L; Bordessoulles, M; Corcuera, L; Franetich, JF; Galiano, S; López de Cerain, A; Mazier, D; Pabón, A; Quiliano, M; Ramirez-Calderon, G; Rios, A; Vettorazzi, A | 1 |
Coelho, P; Prudêncio, C; Silva, L; Soares, R; Vieira, M | 1 |
Li, J; Li, Y; Mao, X; Sumarah, MW; Sun, M; Wang, Y; You, Y | 1 |
Aldana, I; Bonilla-Ramírez, L; Galiano, S; Pabón, A; Quiliano, M | 1 |
Cabrera, M; Cerecetto, H; Corvo, I; Ferraro, F; Gil, J; Merlino, A | 1 |
Coelho, P; Monteiro, A; Pinto, G; Prudêncio, C; Silva, L; Soares, R; Teixeira, D; Vieira, M | 1 |
Rivera, G | 1 |
Agrawal, N; Bhardwaj, A | 1 |
5 review(s) available for quinoxalines and quindoxin
Article | Year |
---|---|
Methylated purines formed in DNA by dimethylnitrosamine in rats previously exposed to hepatotoxic and hepatocarcinogenic regimes: effects on the repair of O6-methylguanine.
Topics: 2-Acetylaminofluorene; Aminobiphenyl Compounds; Animals; Dimethylnitrosamine; DNA; DNA Repair; Ethanolamines; Guanine; Liver; Male; Quinoxalines; Rats; Rats, Inbred Strains | 1985 |
Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Screening Assays, Antitumor; Humans; Mutagenicity Tests; Photochemistry; Quinoxalines; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Mice; Quinoxalines; Structure-Activity Relationship | 2011 |
Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors?
Topics: Mycobacterium tuberculosis; Oxides; Quinoxalines; Structure-Activity Relationship | 2022 |
An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1,4-di-N-oxide scaffold.
Topics: Anti-Bacterial Agents; Oxides; Pharmaceutical Preparations; Quinoxalines | 2022 |
55 other study(ies) available for quinoxalines and quindoxin
Article | Year |
---|---|
Photocontact dermatitis due to quindoxin.
Topics: Aged; Animal Feed; Dermatitis, Contact; Dermatitis, Occupational; Food Additives; Humans; Male; Middle Aged; Photosensitivity Disorders; Quinoxalines | 1975 |
Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli.
Topics: Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Macromolecular Substances; Mutation; Oxidation-Reduction; Quinoxalines | 1978 |
Mutagenicity of quinoline derivatives and analogs-quinoxaline 1,4-dioxide is a potent mutagen.
Topics: Mutagens; Quinolines; Quinoxalines | 1979 |
Photochemical reactions of quindoxin, olaquindox, carbadox and cyadox with protein, indicating photoallergic properties.
Topics: Animals; Anti-Bacterial Agents; Carbadox; Chemical Phenomena; Chemistry; Humans; Organophosphorus Compounds; Photochemistry; Photosensitivity Disorders; Proteins; Quinoxalines; Serum Albumin; Ultraviolet Rays | 1990 |
Genotoxicity of quinoxaline 1,4-dioxide derivatives in Escherichia coli and Salmonella typhimurium.
Topics: Dose-Response Relationship, Drug; Escherichia coli; Mutagenicity Tests; Mutation; Quinoxalines; Salmonella typhimurium; SOS Response, Genetics; Structure-Activity Relationship | 1989 |
Charge transfer in the mechanism of drug action involving quinoxaline di-N-oxides.
Topics: Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Electron Transport; Mutagens; Quinoxalines | 1985 |
Antibacterial properties of quindoxin: a new growth-promoting agent.
Topics: Anaerobiosis; Animals; Bacitracin; Chickens; Clostridium; Cyclic N-Oxides; Escherichia coli; Feces; Growth; Oxytetracycline; Penicillin G; Penicillin Resistance; Quinoxalines; Staphylococcus; Virginiamycin | 1972 |
[Study of the biological effects of quinoxaline-1,4-dioxide].
Topics: Animals; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Chickens; Escherichia coli; Growth; Mutagens; Quinoxalines; Staphylococcus aureus | 1984 |
Feed additives to chick starter mixtures under tropical conditions.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Chickens; Eating; Energy Metabolism; Ethiopia; Female; Food Additives; Male; Nitrofurans; Nitrovin; Quinoxalines; Tropical Climate | 1984 |
Sister-chromatid exchange in Chinese hamster V79 cells exposed to quindoxin, carbadox and olaquindox.
Topics: Animals; Carbadox; Cells, Cultured; Cricetinae; Crossing Over, Genetic; Dose-Response Relationship, Drug; Quinoxalines; Sister Chromatid Exchange; Structure-Activity Relationship | 1984 |
DNA damage induced with near-ultraviolet light irradiation in the presence of quinoxaline-1,4-dioxide.
Topics: Bacillus subtilis; DNA, Bacterial; Mutagens; Quinoxalines; Ultraviolet Rays | 1980 |
Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. I. Micronucleus test in rats.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Carbadox; Cell Nucleus; Erythrocytes; Male; Mutagenicity Tests; Mutagens; Mutation; Quinoxalines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1983 |
Mutagenicity of quindoxin, its metabolites, and two substituted quinoxaline-di-N-oxides.
Topics: Anaerobiosis; Carbadox; Cyclic N-Oxides; DNA Repair; Mutagens; Quinoxalines; Salmonella typhimurium | 1981 |
[The antibacterial, quinoxaline 1,4-dioxide].
Topics: Animals; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Mice; Quinoxalines | 1981 |
Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Survival; Cricetinae; Cricetulus; Female; Mice; Mice, Inbred BALB C; Quinoxalines; Tirapazamine; Triazines; Tumor Cells, Cultured | 1995 |
Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide.
Topics: Antibiotics, Antineoplastic; DNA; DNA Damage; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Hydrolysis; Hypoxia; Oxidation-Reduction; Plasmids; Quinoxalines; Xanthine; Xanthine Oxidase | 2001 |
Quinoxaline 1,4-dioxides: hypoxia-selective therapeutic agents.
Topics: Aerobiosis; Antineoplastic Agents; Cell Hypoxia; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Kinetics; Quinoxalines; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candida; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines | 2002 |
Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
Topics: Antineoplastic Agents; Azides; Computer Simulation; Cyclic N-Oxides; DNA Damage; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; NAD; Oxidation-Reduction; Photolysis; Plasmids; Quinoxalines; Radiation-Sensitizing Agents; Singlet Oxygen; Spectrophotometry; Spin Labels; Tirapazamine; Triazines | 2003 |
Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Lewis Lung; Cell Hypoxia; Cell Survival; Collagen; Combined Modality Therapy; Drug Combinations; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Necrosis; Neovascularization, Pathologic; Proteoglycans; Quinoxalines; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A | 2004 |
Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Quinoxalines | 2004 |
Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Division; Cells, Cultured; Colonic Neoplasms; Cyclin B; Extracellular Signal-Regulated MAP Kinases; Humans; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Topics: Animals; Antitubercular Agents; Cattle; Cell Line; Drug Resistance, Bacterial; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Pulmonary | 2005 |
DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay.
Topics: Apoptosis; Caco-2 Cells; Cell Hypoxia; Cell Nucleus; Cell Proliferation; Cell Survival; Comet Assay; DNA; DNA Damage; DNA Repair; Humans; Mutagens; Oxidation-Reduction; Quinoxalines | 2005 |
Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Copper; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Fibroblasts; Models, Molecular; Organometallic Compounds; Quinoxalines; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Surface Properties | 2005 |
Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Topics: Adipocytes; Animals; Cells, Cultured; Electron Spin Resonance Spectroscopy; Ephedrine; Hypoglycemic Agents; Insulin; Lipolysis; Male; Molecular Mimicry; Molecular Structure; Organometallic Compounds; Quinoxalines; Rats; Rats, Wistar; Vanadates | 2006 |
Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxadiazoles; Quinoxalines; Sarcoma, Experimental | 2006 |
A new efficient route for the formation of quinoxaline N-oxides and N,N'-dioxides using HOF.CH3CN.
Topics: Acetonitriles; Fluorine; Hydrogen; Molecular Structure; Oxidation-Reduction; Oxides; Quinoxalines | 2006 |
Comparative acute systemic toxicity of several quinoxaline 1,4-di-N-oxides in Wistar rats.
Topics: Animals; Body Weight; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Quinoxalines; Rats; Rats, Wistar; Solubility; Structure-Activity Relationship | 2007 |
Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.
Topics: Animals; Antimalarials; Cattle; Cell Survival; Drug Design; Humans; KB Cells; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2008 |
Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives.
Topics: Antitubercular Agents; Fluorine; Mass Spectrometry; Phenols; Quinoxalines | 2008 |
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biotransformation; Drug Resistance, Multiple, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2008 |
New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Electrons; Humans; Inhibitory Concentration 50; Quinoxalines | 2010 |
Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Topics: Nifurtimox; Oxides; Quantitative Structure-Activity Relationship; Quinoxalines; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
Topics: Antineoplastic Agents; Carcinoma; Cell Death; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Quinoxalines; Tumor Suppressor Protein p53 | 2010 |
Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
Topics: Animals; Chlorocebus aethiops; Female; Leishmania; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Molecular Structure; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2011 |
Maximizing bactericidal activity with combinations of bioreduced drugs.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Discovery; Free Radicals; Humans; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Quinoxalines; Tuberculosis | 2010 |
Unusual Friedlander reactions: a route to novel quinoxaline-based heterocycles.
Topics: Crystallography, X-Ray; Cyclopentanes; Molecular Structure; Quinoxalines | 2012 |
Simultaneous determination of quinoxaline-1,4-dioxides in feeds using molecularly imprinted solid-phase extraction coupled with HPLC.
Topics: Adsorption; Animal Feed; Anti-Bacterial Agents; Food Contamination; Molecular Imprinting; Polymers; Quinoxalines; Solid Phase Extraction | 2013 |
Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives.
Topics: Anti-Infective Agents; Candida albicans; Escherichia coli; Microbial Sensitivity Tests; Microbial Viability; Quinoxalines; Saccharomyces cerevisiae; Staphylococcus aureus | 2014 |
N-oxide reduction of quinoxaline-1,4-dioxides catalyzed by porcine aldehyde oxidase SsAOX1.
Topics: Aldehyde Oxidase; Amino Acid Sequence; Amino Acid Substitution; Animals; Catalysis; Circular Dichroism; Cloning, Molecular; Female; Glycine; Liver; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidation-Reduction; Protein Conformation; Quinoxalines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sus scrofa; Threonine | 2014 |
The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Quinoxalines; RNA, Small Interfering; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2014 |
Fragmentation of the quinoxaline N-oxide bond to the ˙OH radical upon one-electron bioreduction.
Topics: Antineoplastic Agents; Humans; Hydroxyl Radical; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Oxides; Pyrroles; Quinoxalines; Tirapazamine; Triazines | 2014 |
Simultaneous determination of five quinoxaline-1,4-dioxides in animal feeds using an immunochromatographic strip.
Topics: Animal Feed; Animals; Antibodies; Antigen-Antibody Reactions; Chromatography, Affinity; Chromatography, High Pressure Liquid; Gold; Metal Nanoparticles; Quinoxalines | 2016 |
Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Topics: Animals; Cell Survival; Chlorocebus aethiops; Nitrogen; Oxides; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2016 |
High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
Topics: Adrenal Gland Diseases; Aldosterone; Antioxidants; Biotransformation; Cell Line; Cell Survival; Cytochrome P-450 CYP11B2; Humans; Oxidative Stress; Proanthocyanidins; Quinoxalines; RNA, Messenger; Steroid 11-beta-Hydroxylase | 2016 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Topics: Antiprotozoal Agents; Humans; Hydrazines; Leishmania infantum; Leishmaniasis, Visceral; Malaria, Falciparum; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2017 |
Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana.
Topics: Animals; Antiprotozoal Agents; Cell Death; Cell Line; Leishmania mexicana; Membrane Potential, Mitochondrial; Mice; Quinoxalines; Reactive Oxygen Species | 2018 |
Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Topics: Animals; Antimalarials; Chloroquine; Female; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Mice, Inbred BALB C; Plasmodium; Primaquine; Quinoxalines | 2018 |
Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Melanoma; Mice; Molecular Structure; Quinoxalines; Structure-Activity Relationship | 2019 |
Tracing major metabolites of quinoxaline-1,4-dioxides in abalone with high-performance liquid chromatography tandem positive-mode electrospray ionization mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Food Contamination; Gastropoda; Quinoxalines; Seafood; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2019 |
Primaquine-quinoxaline 1,4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen species.
Topics: Antimalarials; Drug Combinations; Erythrocytes; Hep G2 Cells; Humans; Plasmodium yoelii; Primaquine; Quinoxalines; Sporozoites | 2019 |
Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-
Topics: Animals; Binding Sites; Cathepsin L; Cattle; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fasciola hepatica; Humans; Inhibitory Concentration 50; Male; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Quinoxalines; Spermatozoa; Structure-Activity Relationship | 2019 |
Oxidative Stress Modulation and Radiosensitizing Effect of Quinoxaline-1,4-Dioxides Derivatives.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Mice; Oxidative Stress; Quinoxalines; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2020 |